IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GRETCHEN M FOLEY

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1437553187
CMS profile
10576672
Location
SPOKANE, WA

General Payments · PY2021–2024

$2,578.27

  • Reported across 126 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,029.38

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Medical WA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,029.38 50

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $601.75 33
Novo Nordisk AS $136.23 2
PFIZER INC. $70.90 4
Boehringer Ingelheim Pharmaceuticals, Inc. $61.15 3
E.R. Squibb & Sons, L.L.C. $33.31 2
Kiniksa Pharmaceuticals International, plc $28.52 1
ABIOMED $25.19 1
Bayer HealthCare Pharmaceuticals Inc. $20.23 1
Merck Sharp & Dohme Corporation $19.76 1
Acerta Pharma LLC $16.19 1
Amgen Inc. $16.15 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $757.97 42
PY2022 $310.25 19
PY2023 $480.67 15
PY2024 $1,029.38 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $25.19 11/14/2024 Food and Beverage Undisputed 01/23/2026 1142283195 CMS
Amgen Inc. $16.15 11/14/2024 Food and Beverage Undisputed 01/23/2026 1115627854 CMS
AstraZeneca Pharmaceuticals LP $16.19 10/20/2024 Food and Beverage Undisputed 01/23/2026 1105900560 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.23 10/31/2024 Food and Beverage Undisputed 01/23/2026 1086303306 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 1118009927 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.62 07/26/2024 Food and Beverage Undisputed 01/23/2026 1118009931 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.24 11/08/2024 Food and Beverage Undisputed 01/23/2026 1118009929 CMS
E.R. Squibb & Sons, L.L.C. $14.63 07/16/2024 Food and Beverage Undisputed 01/23/2026 1101531882 CMS
E.R. Squibb & Sons, L.L.C. $18.68 09/30/2024 Food and Beverage Undisputed 01/23/2026 1101531909 CMS
Kiniksa Pharmaceuticals International, plc $28.52 11/20/2024 Food and Beverage Undisputed 01/23/2026 1154882385 CMS
Merck Sharp & Dohme LLC $19.76 10/25/2024 Food and Beverage Undisputed 01/23/2026 1141864265 CMS
Novartis Pharmaceuticals Corporation $7.13 03/07/2024 Food and Beverage Undisputed 01/23/2026 1086806545 CMS
Novartis Pharmaceuticals Corporation $18.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 1086806547 CMS
Novartis Pharmaceuticals Corporation $17.66 04/18/2024 Food and Beverage Undisputed 01/23/2026 1086806549 CMS
Novartis Pharmaceuticals Corporation $10.09 05/06/2024 Food and Beverage Undisputed 01/23/2026 1086806551 CMS
Novartis Pharmaceuticals Corporation $28.92 06/03/2024 Food and Beverage Undisputed 01/23/2026 1086806559 CMS
Novartis Pharmaceuticals Corporation $8.52 06/03/2024 Food and Beverage Undisputed 01/23/2026 1086806563 CMS
Novartis Pharmaceuticals Corporation $23.26 06/05/2024 Food and Beverage Undisputed 01/23/2026 1086806553 CMS
Novartis Pharmaceuticals Corporation $6.83 06/06/2024 Food and Beverage Undisputed 01/23/2026 1086806555 CMS
Novartis Pharmaceuticals Corporation $21.60 06/11/2024 Food and Beverage Undisputed 01/23/2026 1086806565 CMS
Novartis Pharmaceuticals Corporation $15.96 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086806557 CMS
Novartis Pharmaceuticals Corporation $21.97 06/13/2024 Food and Beverage Undisputed 01/23/2026 1086806561 CMS
Novartis Pharmaceuticals Corporation $5.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086806573 CMS
Novartis Pharmaceuticals Corporation $26.13 07/01/2024 Food and Beverage Undisputed 01/23/2026 1086806567 CMS
Novartis Pharmaceuticals Corporation $28.10 07/02/2024 Food and Beverage Undisputed 01/23/2026 1086806569 CMS
Novartis Pharmaceuticals Corporation $24.44 07/08/2024 Food and Beverage Undisputed 01/23/2026 1086806571 CMS
Novartis Pharmaceuticals Corporation $16.05 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086806575 CMS
Novartis Pharmaceuticals Corporation $22.55 08/02/2024 Food and Beverage Undisputed 01/23/2026 1086806577 CMS
Novartis Pharmaceuticals Corporation $10.34 08/06/2024 Food and Beverage Undisputed 01/23/2026 1086806579 CMS
Novartis Pharmaceuticals Corporation $14.39 08/30/2024 Food and Beverage Undisputed 01/23/2026 1086806581 CMS
Novartis Pharmaceuticals Corporation $23.08 08/30/2024 Food and Beverage Undisputed 01/23/2026 1086806587 CMS
Novartis Pharmaceuticals Corporation $24.21 10/17/2024 Food and Beverage Undisputed 01/23/2026 1086806589 CMS
Novartis Pharmaceuticals Corporation $24.87 10/18/2024 Food and Beverage Undisputed 01/23/2026 1086806591 CMS
Novartis Pharmaceuticals Corporation $11.86 10/24/2024 Food and Beverage Undisputed 01/23/2026 1086806601 CMS
Novartis Pharmaceuticals Corporation $17.56 11/07/2024 Food and Beverage Undisputed 01/23/2026 1086806603 CMS
Novartis Pharmaceuticals Corporation $14.93 11/11/2024 Food and Beverage Undisputed 01/23/2026 1086806605 CMS
Novartis Pharmaceuticals Corporation $16.09 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086806583 CMS
Novartis Pharmaceuticals Corporation $5.21 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086806585 CMS
Novartis Pharmaceuticals Corporation $27.86 11/13/2024 Food and Beverage Undisputed 01/23/2026 1086806599 CMS
Novartis Pharmaceuticals Corporation $22.98 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086806593 CMS
Novartis Pharmaceuticals Corporation $19.41 11/22/2024 Food and Beverage Undisputed 01/23/2026 1086806607 CMS
Novartis Pharmaceuticals Corporation $19.72 12/03/2024 Food and Beverage Undisputed 01/23/2026 1086806597 CMS
Novartis Pharmaceuticals Corporation $20.78 12/10/2024 Food and Beverage Undisputed 01/23/2026 1086806595 CMS
Novartis Pharmaceuticals Corporation $25.08 12/20/2024 Food and Beverage Undisputed 01/23/2026 1086806609 CMS
Novo Nordisk Inc $119.45 08/07/2024 Food and Beverage Undisputed 01/23/2026 1100554717 CMS
Novo Nordisk Inc $16.78 12/18/2024 Food and Beverage Undisputed 01/23/2026 1100277760 CMS
PFIZER INC. $16.87 04/05/2024 Food and Beverage Undisputed 01/23/2026 1131714566 CMS
PFIZER INC. $19.49 04/17/2024 Food and Beverage Undisputed 01/23/2026 1131713335 CMS
PFIZER INC. $15.91 10/04/2024 Food and Beverage Undisputed 01/23/2026 1132108450 CMS
PFIZER INC. $18.63 10/24/2024 Food and Beverage Undisputed 01/23/2026 1132082350 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.